Mylan is one of the world's largest API manufacturers as measured by the number of drug master files on record with regulatory agencies. Mylan uses the APIs it develops to supply its internal network and to sell to third parties. The company operates all nine of its API facilities in India and offers a broad portfolio and pipeline of more than 250 APIs in a variety of therapeutic categories, from antibacterials to antifungals. Mylan has an API capacity of >4800 kiloliters.
REDUCING EFFLUENT DISCHARGE – LEADING BY EXAMPLE
Responsible wastewater treatment is a key topic for our industry and Mylan is committed to leading by example. The production requirements of our operations – coupled with local regulations and infrastructure – guide the type of water and wastewater management applied. In India, we are a leader in zero liquid discharge (ZLD) systems. ZLD systems are wastewater treatment plants that eliminate effluent discharge into the environment or to common treatment plants. Instead, all wastewater is treated and repurposed back into nonpotable applications in our facilities, reducing water usage and significantly reducing environmental impact.